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Introduction
Periodontal wound healing after surgery requires a 
series of cell–cell interactions between epithelial 
cells, gingival fibroblasts (GFs), periodontal ligament 
(PDL) cells, and osteoblasts, whereas disruption of 
the vasculature leads to fibrin formation, platelet 
aggregation, and release of several growth factors 
into tissues from platelets.1 These processes involve 
molecular signals which are primarily mediated by 
cytokines and growth factors. Platelets contain 
various growth factors and cytokines that play key 
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roles in inflammation and wound repair.2 Platelets 
also secrete fibrin, fibronectin, and vitronectin, 
which act as a matrix for connective tissue and as 
adhesion molecules for more efficient cell migra-
tion.3 This has led to the idea of using platelets as 
therapeutic tools to improve tissue repair particu-
larly in periodontal wound healing.
Platelet-rich fibrin (PRF) described by Choukroun 
et al.4 is a second-generation platelet concentrate 
which allows one to obtain fibrin membranes en-
riched with platelets and growth factors, after start-
ing from an anticoagulant-free blood harvest.5,6 
PRF looks like a fibrin network and leads to more 
efficient cell migration and proliferation and thus 
cicatrization. PRF was initially used in implant 
surgery to improve bone healing.4 Despite a lack of 
scientifically proven clinical benefits, the homoge-
neous fibrin network that is obtained is considered 
by the promoters of this technique to be a healing 
biomaterial and is commonly used in implant and 
plastic periodontal surgery procedures to enhance 
bone regeneration and soft-tissue wound healing.7,8 
Compared with other autologous platelet concen-
trates, there are few references in the literature 
about the biologic properties of PRF.
PRF contains platelets, growth factors and cy-
tokines that may enhance the healing potential of 
both bone and soft tissues.1,2 However, the litera-
ture mostly contains studies of the experimental 
use of PRF in animals and humans, and only a few 
in vitro studies on the effects of PRF on cell prolif-
eration and functions have been carried out. The 
aim of this study was to assess the effects of the 
PRF on periodontally related cells. We investigated 
the biologic effects of PRF on the proliferation of 
the GMN human oral epithelial cell line, the U2OS 
human osteoblast cell line, primary human GFs, and 
PDL cells.
Materials and methods
PRF preparation
After receiving approval of the institutional review 
board at Chung Shan Medical University Hospital, 
blood collection was carried out on 10 healthy non-
smoking volunteers. Blood samples were treated 
according to the PRF protocol with a PC-02 table 
centrifuge and collection kits provided by Process 
(Nice, France).3−5 Briefly, samples were taken 
without an anticoagulant in 10-mL glass-coated 
plastic tubes (Becton Dickinson Vacutainer, Becton, 
Dickinson & Co., Franklin Lakes, NJ, USA) and im-
mediately centrifuged at 3000 rpm for 12 minutes. 
A fibrin clot formed in the middle part of the tube 
(Fig. 1A), while the upper part contained acellular 
plasma, and the bottom part contained red cor-
puscles (Fig. 1A). The fibrin clot was easily sepa-
rated from the lower part of the centrifuged blood. 
The PRF clot was gently pressed into a membrane 
with sterile dry gauze (Fig. 1B). PRF membranes 
were minced at 0.5 ˜  0.5 cm for the following 
experiments.
Cell cultures
Human PDL cells9,10 and GFs11,12 were cultured using 
an explant technique as described previously. Human 
PDL cells were cultured from the roots of extracted 
Fibrin clot (PRF)
Red corpuscles base
A
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(Platelet poor plasma)
B
Fig. 1 (A) Platelet-rich fibrin (PRF) formed in the middle part of the tube. The upper part contained acellular plasma, 
and the bottom part contained red corpuscles. (B) The fibrin clot was easily separated from the lower part of the 
centrifuged blood. The platelet-rich fibrin clot was gently pressed between two layers of sterile dry gauze to form a 
membrane.
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third molars. After extraction, teeth were rinsed 
with Hanks’ buffered saline solution and then placed 
in 60-mm Petri dishes containing Dulbecco’s modi-
fied Eagle’s medium (DMEM) and 100 units of peni-
cillin and 100 μg of streptomycin per millimeter. To 
avoid contamination from the gingiva, the PDL was 
carefully removed from the middle third of the 
root with a scalpel. Clinically healthy gingival con-
nective tissues from a third molar extraction were 
used to culture GFs. The fragments from the PDL 
and gingiva were grown in DMEM supplemented with 
10% fetal calf serum (FCS) and antibiotics. Cultures 
were maintained at 37°C in a humidified atmos-
phere of 5% CO2 and 95% air. Cell cultures between 
the third and eighth passages were used.
U2OS cells (American Tissue Type Collection HTB 
96), derived from a human osteogenic sarcoma, were 
cultured in DMEM supplemented with 10% FCS, 
streptomycin at 100 μg/mL, and penicillin at 100 mg/
mL.13 The GNM oral epithelial cell line, derived from 
a patient with T2N2aM0 gingival carcinoma and me-
tastasis to the cervical lymph node,14 was grown in 
RPMI 1640 medium (Gibco Laborato ries, Grand 
Island, NY, USA) supplemented with 10% FCS and 
antibiotics. Confluent cells were detached with 
0.25% trypsin and 0.05% EDTA for 5 minutes, and 
aliquots of separated cells were subcultured. Cells 
were subcultured at a 1:4 split ratio every third day.
Cell viability
Each PRF membrane was covered with a 5-mL sus-
pension of cells at a concentration of 5 ˜  104 cells/
mL in 35-mm culture dishes. After a 3-day culture 
period, the medium was removed, and 0.5 mL of 
0.25% trypsin in phosphate-buffered saline (PBS) 
was added to each culture dish to detach the cells. 
One milliliter of medium was added to 0.5 mL of 
this cell suspension. Then 0.5 mL of calcium- and 
magnesium-free PBS containing 0.25% trypan blue 
(wt/vol) was added to 0.5 mL of the cell suspen-
sion to stain nonviable cells. Fifteen microliters of 
the cell suspension was dropped into a hemocy-
tometer chamber (Cambridge Instruments, Buffalo, 
NY, USA), and cell numbers were counted under a 
phase-contrast microscope.15 Cell viability is rep-
resented as number of viable cells as a percentage 
of total cells.
Cell proliferation assay
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) colorimetric assay was devel-
oped to monitor cell proliferation in vitro.16 To 
elucidate PRF’s role in cell proliferation, cells were 
seeded in 96-well plates at an initial density of 
2 ˜  104 cells per well in DMEM containing PRF for 
3 days. In the final 4 hours, 50 μL of the MTT solution 
was added to each well. Only the mitochondria of 
viable cells can reduce MTT to formazan. The pro-
duced insoluble formazan was dissolved with 150 μL 
of DMSO to each well. Reduced MTT was then 
measured spectrophotometrically in a dual-beam 
microtiter plate reader at 570 nm with 650 nm as a 
reference. Optical density values of the experi-
mental groups were divided by the control value 
and are expressed as a percentage of the control.
Statistical analysis
Triplicate experiments were performed throughout 
this study. All assays were repeated three times to 
ensure reproducibility. The significance of the re-
sults obtained from the control and treated groups 
were statistically analyzed by Student’s t test.
Results
The results of cell viability by trypan blue dye are 
shown in Fig. 2. PRF exhibited no cytotoxic effects 
to the four types of periodontally related cells 
(P > 0.05). Each type of cell maintained its original 
morphology. Cells from gingiva (Fig. 3A) and the PDL 
(Fig. 3B) on the flat surface of the culture dishes 
exhibited a spindle-shaped morphology. Cells of the 
GMN oral epithelial cell line (Fig. 3C) and U2OS oste-
oblast cell line (Fig. 3D) have a cuboid/flat appear-
ance. Moreover, GFs, PDL cells, and osteoblasts were 
also found to attach at the margin of PRF under 
observation by phase-contrast microscopy.
Figure 4 shows the effects of PRF on periodon-
tally related cells. The cell density and number 
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Fig. 2 No differences in cell viability between controls 
and platelet-rich fibrin (PRF) groups with periodontally 
related cells (P > 0.05). PDL = periodontal ligament cells; 
GF = gingival fibroblasts.
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gradually increased during the 3-day incubation 
period. PRF was found to increase PDL, GF and os-
teoblast proliferation, and cell numbers increased 
about 1.2-, 1.3- and 1.35-fold, respectively (P < 0.05). 
However, PRF was found to reduce the epithelial 
cell number by about 20% compared with the un-
treated control (P < 0.05).
Discussion
The simple and open-access technique of PRF was 
first developed in France by Choukroun et al.,4 and 
PRF is produced in a totally natural manner, with-
out using an anticoagulant during blood harvesting 
or bovine thrombin or calcium chloride for platelet 
activation and fibrin polymerization. The protocol 
is very simple and cheap. Venous blood is collected 
in dry 10-mL glass tubes, and centrifuged at about 
400g for 12 minutes.3−6 After centrifugation, three 
layers are formed in the tube: a base of red blood 
cells at the bottom, acellular plasma on the top 
(supernatant), and a clot of PRF between them. 
A B
C D
Fig. 3 Periodontally related cells maintained their original morphology when cultured with platelet-rich fibrin 
membranes. (A) Gingival fibroblasts; (B) periodontal ligament cells; (C) epithelial cells; and (D) osteoblasts.
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Fig. 4 Effects of platelet-rich fibrin (PRF) on periodon-
tally related cells. Cells were exposed to PRF for 3 days. 
Viable cell numbers were measured with an MTT assay. 
The percentage of absorbance of each cell with PRF 
compared with that of the control was calculated. Each 
point and bar represent the mean ± standard deviation. 
*Signifi cant difference from the control value at P < 0.05. 
PDL = periodontal ligament cells; GF = gingival fibroblasts.
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PRF presents a complex tridimensional architecture 
which truly makes it a platelet- and leukocyte-rich 
fibrin biomaterial.5,6 When delicately pressed be-
tween two layers of gauze, the PRF clot becomes 
a strong membrane with high potential, both for 
clinical applications7,8,17,18 and tissue engineering.19
In this study, PRF exhibited no cytotoxicity to 
periodontally related cells. Our results are in 
agreement with Dohan et al.,20 who reported that 
PRF exhibited no cytotoxicity toward preadipocytes, 
keratinocytes, osteoblasts, or GFs. Thus, the bio-
compatibility of PRF is not cell type-specific. Taken 
together, PRF acts as a biomaterial to periodontally 
related cells.
To the best of our knowledge, we first found that 
PRF stimulated osteoblast, GF, and PDL cell prolif-
eration as a mitogen. The mechanism responsible 
for the cell proliferation by PRF might be explained 
as follows. Many growth factors such as platelet-
derived growth factor (PDGF) and transforming 
growth factor (TGF)-β, are released from PRF.5,6,21 
Recently, Dohan et al.21 demonstrated that the PRF 
membrane has a very significant slow sustained re-
lease of key growth factors for at least 1 week, 
which means that the membrane stimulates its en-
vironment for a significant time during remodeling. 
The properties of this natural fibrin biomaterial 
thus offer great potential during wound healing.
Interestingly, PRF was found to inhibit epithelial 
cell proliferation. These biologic actions seem very 
similar to those of previous reports. PDGF and TGF-β 
stimulate mitogenic activity in osteoblasts,22,23 
GFs,24 and PDL cells,23,24 but TGF-β acts as a growth 
inhibitor for epithelial cells.25,26 Taken together, 
with our data on growth factor levels, these findings 
suggest that PRF possibly modulates cell prolifera-
tion by PDGF- and TGF-β-related mechanisms.
In this study, PRF exhibited no cytotoxicity to 
epithelial cells according to a trypan blue assay. 
The MTT assay is also a kind of cytotoxicity assay. 
However, epithelial cells seemed to be negatively 
influenced by PRF according to the MTT assay. The 
reasons are not conflicting and may be explained 
as follows. The trypan blue assay exhibits the per-
centage of cell viability. The MTT assay is a colori-
metric method for quantifying viable cell numbers. 
The methyl-tetrazolium ring is cleared by mito-
chondrial dehydrogenases in viable cells to forma-
zan, which has a blue color and can be measured 
with a spectrophotometer.27 Dead cells are unable 
to produce the colored formazan product; this assay 
can distinguish live from dead cells. In addition, 
epithelial cells presented a typical cuboid/flat 
appearance under observations by phase-contrast 
microscopy in the present study. Taken together, 
PRF did not interfere with epithelial cell viability, 
but it retarded the proliferation of epithelial cells.
As far as we know, this is the first attempt to 
evaluate the role of PRF in human periodontally 
related cells in vitro. We demonstrated that PRF 
exhibits non-cytotoxic effects toward periodontally 
related cells. PRF can stimulate osteoblast, GF and 
PDL cell growth and retard epithelial cell prolifer-
ation. PRF may modulate cell proliferation in a cell 
type-specific manner (Fig. 5). The ability of PRF to 
suppress epithelial cell proliferation seems benefi-
cial for periodontal regeneration. The retardation 
of the down-growth of junctional epithelium to the 
root surfaces in the regeneration procedure might 
avoid interference by the epithelium with the for-
mation of new attachment on root surfaces.
It is our opinion that in vitro experiments are 
very helpful for assaying the biologic effects of PRF 
on periodontally related cells, but they may be lim-
ited in their ability to simulate clinical conditions. 
It may be unrealistic to translate in vitro findings 
to in vitro situations. These in vitro observations 
are very likely to be extrapolated to animal studies 
such as periodontitis models or critical-sized bony 
defect models to clarify the potential benefits of 
using PRF in periodontal regeneration.
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